Follow the Zealand Pharma A/S stock price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares trade on the DK market, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has recorded 59 public disclosures. Market capitalisation: €22.2bn. The latest transaction was disclosed on 28 August 2026 (Sale). All data is free.
59
Insider Decl.
n/a
Thresholds
€341,229
5 ops.
Buy Volume
€6m
19 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zealand Pharma A/S Buy (bullish), based on 14 analysts. Average price target: DKK 441.93.
25Σ signal
Buys €341,229€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26 of 29,063 companies
94.9
score / 100
Value
97
Quality
93
FCF yld32%
Earn yld32%
EV/EBITDA2.9x
ROE16%
Gross mgn100%
Net mgn70%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.